Characterization of an immunosuppressive anti-CD40 ligand monoclonal antibody

Kwang Mi Kim, Hye Young Min, Seung Hye Jung, Tae Ho Lee, Joong Gon Kim, Chang Yuil Kang

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The interaction between CD40 ligand (CD40L) and its counter-receptor CD40 is critically important in T and B-cell costimulation and generation of the humoral immune response. But several questions still remain unsolved, particularly in the human in vivo system. To clarify the precise function of CD40L and develop an immunosuppressive agent, we have generated a murine monoclonal antibody (MAb), 2B2 specific for human CD40L. The specificity of this MAb for human CD40L was verified by enzyme-linked immunoadsorbent assay (ELISA) and flow cytometry. MAb 2B2 immunoprecipitated proteins of molecular weight 35 and 28 kD on human peripheral blood lymphocytes (PBLs) stimulated with phorbol 12-myristate-13-acetate (PMA) plus ionomycin. Then we have studied the biological effect of MAb 2B2 in severe combined immunodeficiency (SCID) mice reconstituted with human PBLs. The data showed that this MAb strongly suppressed human IgG production of human B cells transplanted in SCID mice, indicating that this MAb 2B2 could be used to regulate unwanted immune responses associated with autoimmune disease. Then we analyzed the sequence of MAb 2B2. The 2B2 heavy chain variable region (V(H)) and light chain variable region (V(L)) genes were cloned using PCR. The cloned V(H) gene coded for 123 amino acid residues and belonged to the subgroup III(D). The V(L) gene coded for 126 amino acid and belonged to the subgroup V. Collectively, these results will be used to develop an immunosuppressive chimeric or humanized anti-CD40L antibody.

Original languageEnglish
Pages (from-to)463-470
Number of pages8
JournalHybridoma
Volume17
Issue number5
DOIs
Publication statusPublished - 1998 Jan 1

Fingerprint

CD40 Ligand
Immunosuppressive Agents
Monoclonal Antibodies
Severe Combined Immunodeficiency
B-Lymphocytes
Lymphocytes
Genes
Amino Acids
Immunosorbents
Ionomycin
Humoral Immunity
Autoimmune Diseases
Flow Cytometry
Acetates
Immunoglobulin G
Molecular Weight
Light
Polymerase Chain Reaction
Antibodies
Enzymes

All Science Journal Classification (ASJC) codes

  • Immunology
  • Genetics

Cite this

Kim, Kwang Mi ; Min, Hye Young ; Jung, Seung Hye ; Lee, Tae Ho ; Kim, Joong Gon ; Kang, Chang Yuil. / Characterization of an immunosuppressive anti-CD40 ligand monoclonal antibody. In: Hybridoma. 1998 ; Vol. 17, No. 5. pp. 463-470.
@article{7018a18889144a788e8c4f205c617ef8,
title = "Characterization of an immunosuppressive anti-CD40 ligand monoclonal antibody",
abstract = "The interaction between CD40 ligand (CD40L) and its counter-receptor CD40 is critically important in T and B-cell costimulation and generation of the humoral immune response. But several questions still remain unsolved, particularly in the human in vivo system. To clarify the precise function of CD40L and develop an immunosuppressive agent, we have generated a murine monoclonal antibody (MAb), 2B2 specific for human CD40L. The specificity of this MAb for human CD40L was verified by enzyme-linked immunoadsorbent assay (ELISA) and flow cytometry. MAb 2B2 immunoprecipitated proteins of molecular weight 35 and 28 kD on human peripheral blood lymphocytes (PBLs) stimulated with phorbol 12-myristate-13-acetate (PMA) plus ionomycin. Then we have studied the biological effect of MAb 2B2 in severe combined immunodeficiency (SCID) mice reconstituted with human PBLs. The data showed that this MAb strongly suppressed human IgG production of human B cells transplanted in SCID mice, indicating that this MAb 2B2 could be used to regulate unwanted immune responses associated with autoimmune disease. Then we analyzed the sequence of MAb 2B2. The 2B2 heavy chain variable region (V(H)) and light chain variable region (V(L)) genes were cloned using PCR. The cloned V(H) gene coded for 123 amino acid residues and belonged to the subgroup III(D). The V(L) gene coded for 126 amino acid and belonged to the subgroup V. Collectively, these results will be used to develop an immunosuppressive chimeric or humanized anti-CD40L antibody.",
author = "Kim, {Kwang Mi} and Min, {Hye Young} and Jung, {Seung Hye} and Lee, {Tae Ho} and Kim, {Joong Gon} and Kang, {Chang Yuil}",
year = "1998",
month = "1",
day = "1",
doi = "10.1089/hyb.1998.17.463",
language = "English",
volume = "17",
pages = "463--470",
journal = "Monoclonal Antibodies in Immunodiagnosis and Immunotherapy",
issn = "2167-9436",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

Characterization of an immunosuppressive anti-CD40 ligand monoclonal antibody. / Kim, Kwang Mi; Min, Hye Young; Jung, Seung Hye; Lee, Tae Ho; Kim, Joong Gon; Kang, Chang Yuil.

In: Hybridoma, Vol. 17, No. 5, 01.01.1998, p. 463-470.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Characterization of an immunosuppressive anti-CD40 ligand monoclonal antibody

AU - Kim, Kwang Mi

AU - Min, Hye Young

AU - Jung, Seung Hye

AU - Lee, Tae Ho

AU - Kim, Joong Gon

AU - Kang, Chang Yuil

PY - 1998/1/1

Y1 - 1998/1/1

N2 - The interaction between CD40 ligand (CD40L) and its counter-receptor CD40 is critically important in T and B-cell costimulation and generation of the humoral immune response. But several questions still remain unsolved, particularly in the human in vivo system. To clarify the precise function of CD40L and develop an immunosuppressive agent, we have generated a murine monoclonal antibody (MAb), 2B2 specific for human CD40L. The specificity of this MAb for human CD40L was verified by enzyme-linked immunoadsorbent assay (ELISA) and flow cytometry. MAb 2B2 immunoprecipitated proteins of molecular weight 35 and 28 kD on human peripheral blood lymphocytes (PBLs) stimulated with phorbol 12-myristate-13-acetate (PMA) plus ionomycin. Then we have studied the biological effect of MAb 2B2 in severe combined immunodeficiency (SCID) mice reconstituted with human PBLs. The data showed that this MAb strongly suppressed human IgG production of human B cells transplanted in SCID mice, indicating that this MAb 2B2 could be used to regulate unwanted immune responses associated with autoimmune disease. Then we analyzed the sequence of MAb 2B2. The 2B2 heavy chain variable region (V(H)) and light chain variable region (V(L)) genes were cloned using PCR. The cloned V(H) gene coded for 123 amino acid residues and belonged to the subgroup III(D). The V(L) gene coded for 126 amino acid and belonged to the subgroup V. Collectively, these results will be used to develop an immunosuppressive chimeric or humanized anti-CD40L antibody.

AB - The interaction between CD40 ligand (CD40L) and its counter-receptor CD40 is critically important in T and B-cell costimulation and generation of the humoral immune response. But several questions still remain unsolved, particularly in the human in vivo system. To clarify the precise function of CD40L and develop an immunosuppressive agent, we have generated a murine monoclonal antibody (MAb), 2B2 specific for human CD40L. The specificity of this MAb for human CD40L was verified by enzyme-linked immunoadsorbent assay (ELISA) and flow cytometry. MAb 2B2 immunoprecipitated proteins of molecular weight 35 and 28 kD on human peripheral blood lymphocytes (PBLs) stimulated with phorbol 12-myristate-13-acetate (PMA) plus ionomycin. Then we have studied the biological effect of MAb 2B2 in severe combined immunodeficiency (SCID) mice reconstituted with human PBLs. The data showed that this MAb strongly suppressed human IgG production of human B cells transplanted in SCID mice, indicating that this MAb 2B2 could be used to regulate unwanted immune responses associated with autoimmune disease. Then we analyzed the sequence of MAb 2B2. The 2B2 heavy chain variable region (V(H)) and light chain variable region (V(L)) genes were cloned using PCR. The cloned V(H) gene coded for 123 amino acid residues and belonged to the subgroup III(D). The V(L) gene coded for 126 amino acid and belonged to the subgroup V. Collectively, these results will be used to develop an immunosuppressive chimeric or humanized anti-CD40L antibody.

UR - http://www.scopus.com/inward/record.url?scp=0031696782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031696782&partnerID=8YFLogxK

U2 - 10.1089/hyb.1998.17.463

DO - 10.1089/hyb.1998.17.463

M3 - Article

C2 - 9873992

AN - SCOPUS:0031696782

VL - 17

SP - 463

EP - 470

JO - Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

JF - Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

SN - 2167-9436

IS - 5

ER -